Epidermal growth factor-induced heparanase nucleolar localization augments DNA topoisomerase I activity in brain metastatic breast cancer

Molecular Cancer Research

Volumn 8, Issue 2, 2010, Pages 278-290

  Zhang, Lixin ^a   Sullivan, Peggy ^b   Suyama, Julie ^a   Marchetti, Dario ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA TOPOISOMERASE; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; HEPARANASE; SMALL INTERFERING RNA;

ARTICLE; BRAIN METASTASIS; BREAST CANCER; CELL MIGRATION; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; DNA REPLICATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MOLECULAR MECHANICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; BRAIN NEOPLASMS; BREAST NEOPLASMS; CARCINOMA; CELL LINE, TUMOR; CELL NUCLEOLUS; DNA TOPOISOMERASES, TYPE I; DOWN-REGULATION; EPIDERMAL GROWTH FACTOR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLUCURONIDASE; HUMANS; MICE; MICE, NUDE; MODELS, BIOLOGICAL; NEOPLASM METASTASIS; PROTEIN TRANSPORT; RECEPTOR, ERBB-2; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

MAMMALIA;

EID: 77249112379     PISSN: 15417786     EISSN: None     Source Type: Journal    
DOI: 10.1158/1541-7786.MCR-09-0375     Document Type: Article

References (29)

1. El Kamar FG, Posner JB. Brain metastases. Semin Neurol 2004;4: 347-62.
2. Gril B, Palmieri D, Bronder JL, et al. Effect of lapatinib on the outgrowth of metastatic breast cancer cells to the brain. J Natl Cancer Inst 2008;100:1092-103.
3. Ilan N, Elkin M, Vlodavsky I. Regulation, function, and clinical significance of heparanase in cancer metastasis and angiogenesis. Int J Biochem Cell Biol 2006;38:2018-39.
4. Murry BP, Blust BE, Singh A, Foster TP, Marchetti D. Heparanase mechanisms of melanoma metastasis to the brain: development and use of a brain slice model. J Cell Biochem 2006;97:217-25.
5. Murry BP, Greiter-Wilke A, Paulsen DP, Hiatt KM, Beltrami CA, Marchetti D. Selective heparanase localization in malignant melanoma. Int J Oncol 2005;26:345-52.
6. Marchetti D, Nicolson GL. Human heparanase: a molecular determinant of brain metastasis. Adv Enzyme Reg 2001;41:343-59.
7. Ferro V, Dredge K, Liu L, et al. PI-88 and novel heparan sulfate mimetics inhibit angiogenesis. Sem Thromb Hemost 2007;33: 55-68.
8. Vreys V, David G. Mammalian heparanase: what is the message? J Cell Mol Med 2007;11:427-52.
9. Cohen-Kaplan V, Doweck I, Naroditsky I, Vlodavsky I, Ilan N. Heparanase augments epidermal growth factor receptor phosphorylation: correlation with head and neck tumor progression. Cancer Res 2008; 68:10077-85.
10. Hynes NE. Targeting ERBB receptors in cancer. Rec Results in Cancer Res 2007;172:45-57.
11. Palmieri D, Bronder JL, Herring JM, et al. Her-2 overexpression increases the metastatic outgrowth of breast cancer cells in the brain. Cancer Res 2007;67:4190-8.
12. Kim LS, Huang S, Lu W, Lev DC, Price JE. Vascular endothelial growth factor expression promotes the growth of breast cancer brain metastases in nude mice. Clin Exp Metastasis 2004;21:107-18.
13. Muller MT, Pfund WP, Mehta VB, Trask DK. Eukaryotic type I topoisomerase is enriched in the nucleolus and catalytically active on ribosomal DNA. EMBO J 1985;4:1237-43.
14. Yamashita Y, Krauze MT, Kawaguchi T, et al. Convection-enhanced delivery of a topoisomerase I inhibitor (nanoliposomal topotecan) and a topoisomerase II inhibitor (pegylated liposomal doxorubicin) in intracranial brain tumor xenografts. Neuro-Oncology 2007;9:20-8.
15. Kovalszky I, Dudás J, Oláh-Nagy J, et al. Inhibition of DNA topoisomerase I activity by heparan sulfate and modulation by basic fibroblast growth factor. Mol Cell Biochem 1998;183:11-23.
16. Bos PD, Zhang XH, Nadal C, et al. Genes that mediate breast cancer metastasis to the brain. Nature 2009;459:1-8.
17. Zetser A, Levy-Adam F, Kaplan V, et al. Processing and activation of latent heparanase occurs in lysosomes. J Cell Sci 2004;117:2249-58.
18. Ochs RL, Lischwe MA, Spohn WH, Bush H. Fibrillarin: a new protein of the nucleolus identified by autoimmune sera. Biol Cell 1985;54: 123-33.
19. Sullivan GJ, Bridger JM, Cuthbert AP, Newbold RF, Bickmore WA, McStay B. Human acrocentric chromosomes with transcriptionally silent nucleolar organizer regions associate with nucleoli. EMBO J 2001;20:2867-74.
20. Roy M, Reiland J, Murry BP, Chouljenko V, Kousoulas KG, Marchetti D. Antisense-mediated suppression of Heparanase gene inhibits melanoma cell invasion. Neoplasia 2005;7:253-62.
21. Miao HQ, Elkin M, Aingorn E, Ishai-Michaeli R, Stein C, Vlodavsky I. Inhibition of heparanase activity and tumor metastasis by laminarin sulfate and synthetic phosphorothioate oligodeoxynucleotides. Int Journ Cancer 1999;83:424-31.
22. Schubert SY, Ilan N, Shushy M, Ben-Izhak O, Vlodavsky I, Goldshmidt O. Human heparanase nuclear localization and enzymatic activity. Lab Invest 2004;84:535-44.
23. Ohkawa T, Naomoto Y, Takaoka M, et al. Localization of heparanase in esophageal cancer cells: respective roles in prognosis and differentiation. Lab Invest 2004;84:1289-304.
24. Kobayashi M, Naomoto Y, Nobuhisa T, Okawa T, Takaoka M, Shirakawa Y, et al. Heparanase regulates esophageal keratinocyte differentiation through nuclear translocation and heparan sulfate cleavage. Differentiation 2006;74:235-43.
25. Nobuhisa T, Naomoto Y, Okawa T, et al. Translocation of heparanase into nucleus results in cell differentition. Cancer Sci 2007;98:535-40.
26. Pourquier P, Pommier Y. Topoisomerase I-mediated DNA damage. Adv Cancer Res 2001;80:189-216.
27. Lynch B, Bronstein IB, Holden JA. Elevation of DNA Topoisomerase I in invasive carcinoma of the breast. Breast Journal 2001;7:176-80.
28. Tomicic MT, Christmann M, Kaina B. Topotecan-triggered degradation of Topoisomerase I is p53-dependent and impacts cell survival. Cancer Research 2005;65:8920-6.
29. Pollard JW. Macrophages define the invasive microenvironment in breast cancer. J Leuk Biology 2008;84:623-30.